Geode Capital Management, LLC Royalty Pharma PLC Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Geode Capital Management, LLC holds 7,312,551 shares of RPRX stock, worth $237 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,312,551

Previous 7,265,786 0.64%

Holding current value

$237 Million

Previous $206 Million 9.25%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$24.28 - $28.39 $1.14 Million - $1.33 Million	46,765 Added 0.64%	7,312,551 $187 Million
Q3 2024 Nov 12, 2024	BUY	$25.63 - $29.27 $10.7 Million - $12.2 Million	417,490 Added 6.1%	7,265,786 $206 Million
Q2 2024 Aug 09, 2024	BUY	$26.26 - $29.9 $7.88 Million - $8.98 Million	300,242 Added 4.59%	6,848,296 $181 Million
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $4.95 Million - $5.65 Million	180,443 Added 2.83%	6,548,054 $199 Million
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $6.97 Million - $7.77 Million	266,057 Added 4.36%	6,367,611 $179 Million
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $1.16 Million - $1.39 Million	-44,310 Reduced 0.72%	6,101,554 $166 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $4.55 Million - $5.62 Million	153,738 Added 2.57%	6,145,864 $189 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $5.42 Million - $6.51 Million	165,332 Added 2.84%	5,992,126 $216 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $21.7 Million - $24.4 Million	555,060 Added 10.53%	5,826,794 $230 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $8.8 Million - $9.85 Million	220,646 Added 4.37%	5,271,734 $212 Million
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $1.56 Million - $1.83 Million	41,439 Added 0.83%	5,051,088 $212 Million
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $11 Million - $12.5 Million	-294,473 Reduced 5.55%	5,009,649 $195 Million
Q4 2021 Feb 11, 2022	BUY	$35.17 - $42.48 $40 Million - $48.3 Million	1,136,073 Added 27.26%	5,304,122 $211 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $78.9 Million - $92.2 Million	2,183,363 Added 110.01%	4,168,049 $151 Million
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $2.16 Million - $2.53 Million	54,236 Added 2.81%	1,984,686 $81.2 Million
Q1 2021 May 12, 2021	BUY	$42.34 - $52.82 $28.7 Million - $35.8 Million	677,943 Added 54.13%	1,930,450 $84.1 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $6.06 Million - $8.39 Million	167,664 Added 15.46%	1,252,507 $62.6 Million
Q3 2020 Nov 13, 2020	BUY	$38.56 - $48.36 $9.82 Million - $12.3 Million	254,569 Added 30.66%	1,084,843 $45.6 Million
Q2 2020 Aug 13, 2020	BUY	$44.5 - $52.11 $36.9 Million - $43.3 Million	830,274 New	830,274 $40.3 Million

Others Institutions Holding RPRX

# of Institutions

424

Shares Held

285M

Call Options Held

566K

Put Options Held

36.2K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Royalty Pharma PLC Transaction History